Lilly's antibody preserves muscle, Novo Nordisk ends Hims deal, China approves first dual GLP-1/GCG obesity drug, and more!
The Gut Punch Weekly #26
Lilly's antibody preserves muscle, Novo Nordisk ends Hims deal, China approves first dual GLP-1/GCG obesity drug, and more!